Cumberland Pharmaceuticals clinical trials
The registry lists 49 studies whose lead sponsor is Cumberland Pharmaceuticals. 1 is recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 2, 2026.
Our grouping of 1 registry name, not the registry’s. See them and correct one ↓
- 49studies on the registry
- 1open to participants now
Get an email when these change. Save the Cumberland Pharmaceuticals studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
What it is testing
The drugs Cumberland Pharmaceuticals’ studies test, most open studies first — 10 drugs with a page of their own. Each count opens the studies in search.
Open now Not open: under way, finished or stopped
- 1 open · 7
- 1 open · 1
- conivaptan6 in phase 30 open · 12
- Ibuprofen7 in phase 30 open · 12
- telavancin5 in phase 30 open · 10
- Ibuprofen Injection3 in phase 30 open · 3
- Acetylcysteine1 in phase 30 open · 1
- 0 open · 1
- 0 open · 1
- 0 open · 1
All 49 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 07
- 08
- 609
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started; 14 started before 2007. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Cumberland Pharmaceuticals.
- Cumberland Pharmaceuticals49 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 49 of 49.
- Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)RecruitingNCT05571059Phase 2
- Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial HypertensionActive, not recruitingNCT02682511Phase 2
- Oral Ifetroban in Subjects With Duchenne Muscular DystrophyCompletedNCT03340675Phase 2
- Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)CompletedNCT03028350Phase 2
- Telavancin Pediatric PK Study (Ages >12 Months to 17 Years)TerminatedNCT02013141Phase 1
- Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous IbuprofenCompletedNCT01334957Phase 4
- Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous IbuprofenCompletedNCT01334944Phase 4
- Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic PatientsCompletedNCT03611010Phase 2
- Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic PatientsCompletedNCT02802228Phase 2
- Safety and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric PatientsCompletedNCT02583399Phase 4
- VIBATIV Pregnancy RegistryWithdrawnNCT01130324
- A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia TrialTerminatedNCT02208063Phase 3
- Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus AureusCompletedNCT00124020Phase 3
- Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus AureusCompletedNCT00091819Phase 3
- Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)CompletedNCT00077675Phase 2
- Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus AureusCompletedNCT00107952Phase 3
- Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)CompletedNCT00061633Phase 2
- Telavancin for Treatment of Uncomplicated Staphylococcus Aureus BacteremiaCompletedNCT00062647Phase 2
- Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus AureusCompletedNCT00107978Phase 3
- A Study to Evaluate the Effect of Renal Function on the Biological Activity of TelavancinCompletedNCT01238796Phase 1
- Telavancin Observational Use Registry (TOUR)CompletedNCT02288234
- Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory DiseaseCompletedNCT02216357Phase 2
- Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome PatientsCompletedNCT01436500Phase 2
- Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric PatientsCompletedNCT01002573Phase 3
- Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric Patients Undergoing TonsillectomyCompletedNCT01332253Phase 3
- A Pilot Study to Determine the Efficacy of Intravenous Ibuprofen for Pain Control Following Arthroscopic Knee SurgeryCompletedNCT01650519Phase 4
- Trial of Caldolor for Treatment of Pain in Post-Operative Adult PatientsCompletedNCT00225732Phase 3
- Efficacy of Intravenous Ibuprofen Compared to Intravenous Ketorolac for Pain Control Following Arthroscopic Knee SurgeryCompletedNCT01901393Phase 4
- A Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol®) in Pediatric Subjects With Euvolemic or Hypervolemic HyponatremiaTerminatedNCT01451411Phase 3
- Efficacy and Safety of Bisacodyl and Lactulose as a Preparation for ColonoscopyCompletedNCT02123017Phase 2
- Efficacy and Safety Study of Caldolor (IV Ibuprofen) in Hospitalized Adult Orthopedic PatientsCompletedNCT00470600Phase 3
- 2 Regimens of Lactulose for Colonoscopy Preparation in AdultsCompletedNCT01887470Phase 2
- Pharmacokinetic Study Of Ibuprofen Injection (IVIb) In Healthy Adult SubjectsCompletedNCT00867880Phase 1
- Safety and Efficacy Study of a New Formulation of Acetylcysteine InjectionTerminatedNCT01118663Phase 3
- A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic HyponatremiaCompletedNCT00435591Phase 4
- Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic HyponatremiaCompletedNCT00478192Phase 3
- Safety and Efficacy of Conivaptan in Hyponatremic Patients With Symptomatic Acute Decompensated Heart Failure (ADHF)TerminatedNCT00843986Phase 3
- A Study to Assess the Safety and Effects of Intravenous (IV) Conivaptan on the Hepatic Hemodynamic Response in Cirrhotic PatientsCompletedNCT00592475Phase 2
- Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Liver FunctionCompletedNCT00851227Phase 1
- Study to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Subjects With Normal Kidney FunctionCompletedNCT00887627Phase 1
- A Study to Assess the Effect of Severe Hepatic Impairment on the Pharmacokinetics of Intravenous ConivaptanCompletedNCT01370148Phase 1
- Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic HyponatremiaCompletedNCT00380575Phase 3
- Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic HyponatremiaCompletedNCT00492037Phase 3
- Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart FailureCompletedNCT00057356Phase 2
- An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic HyponatremiaCompletedNCT00379847Phase 3
- A Preference Study Comparing Kristalose® and Liquid LactuloseCompletedNCT00712543Phase 4
- Efficacy and Safety Study of Caldolor (Intravenous Ibuprofen) in Hospitalized Adult and Pediatric Burn PatientsCompletedNCT00606489Phase 3
- Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Adult Febrile PatientsCompletedNCT01131000Phase 3
- A Study of Caldolor in Hospitalized Febrile Pediatric PatientsCompletedNCT00225706Phase 3